Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

18.2%

2 terminated/withdrawn out of 11 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 3

2(28.6%)

7Total

N/A(5)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT06217302Phase 3Recruiting

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Role: collaborator

NCT06867731Enrolling By Invitation

Endosonographic Shear Wave Elastography to Assess Liver and Splenic Fibrosis

Role: lead

NCT02424929Not ApplicableCompleted

Asleep Versus Awake Deep Brain Stimulation Surgery

Role: lead

NCT03334318Completed

PERL Continuous Glucose Monitoring (CGM) Study

Role: collaborator

NCT02631850Not ApplicableCompleted

Effectiveness of Virtual Reality Gaming Therapy Versus CI Therapy for Upper Extremity Rehabilitation

Role: collaborator

NCT02433860Not ApplicableCompleted

Evaluation of the Effectiveness of Pharmacists in Implementing the SCRIPT Protocol

Role: lead

NCT01459770Not ApplicableCompleted

Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD

Role: lead

NCT02036944Terminated

Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting

Role: lead

NCT01717014Not ApplicableTerminated

Radial Reload Open LAR Case Series

Role: collaborator

NCT01614353Unknown

Medication-taking Preferences & Practices of Patients With Chronic Conditions

Role: collaborator

NCT00269425Phase 3Completed

The Heart Institute of Spokane Diet Study

Role: collaborator

All 11 trials loaded